AAD: Continuous Improvements Seen Through 68 Weeks for Deuruxolitinib in Alopecia

TUESDAY, March 19, 2024 -- For adults with alopecia areata, continuous improvements are seen through 68 weeks with deuruxolitinib, according to a study presented at the annual meeting of the American Academy of Dermatology, held from March 8 to 12...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news